[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352118-105":59,"doc-detail-352118-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","loss-of-timm8a-inhibits-breast-cancer-progression-through-promoting-hspa9-ubiquitination-and-degradation-via-competitive-interaction-with-rnf4","Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4","","Investigates TIMM8A’s role and molecular mechanism in breast cancer progression. TIMM8A levels in tissues and cell lines are quantified, and knockdown effects on proliferation, metastasis, and apoptosis are tested in BT549 and MCF-7 cells. Co-immunoprecipitation and ubiquitination assays evaluate TIMM8A’s interaction with HSPA9 and the E3 ligase RNF4, while PI3K/AKT signaling is measured by Western blotting. Xenograft experiments assess tumor growth and show TIMM8A silencing reduces HSPA9, Ki-67, and PI3K/AKT phosphorylation, identifying the TIMM8A/HSPA9/PI3K-AKT axis as a prognostic biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/loss-of-timm8a-inhibits-breast-cancer-progression-through-promoting-hspa9-ubiquitination-and-degradation-via-competitive-interaction-with-rnf4/352118/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/loss-of-timm8a-inhibits-breast-cancer-progression-through-promoting-hspa9-ubiquitination-and-degradation-via-competitive-interaction-with-rnf4/352118.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the primary purpose of this study on TIMM8A in breast cancer?","Question",{"text":112,"@type":113},"The study investigates TIMM8A’s role and underlying mechanisms in breast cancer progression, focusing on how it affects key signaling and protein stability.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TIMM8A influence HSPA9 and its degradation?",{"text":117,"@type":113},"TIMM8A interacts with HSPA9 and maintains HSPA9 protein stability by inhibiting RNF4-mediated ubiquitination and degradation.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the proposed TIMM8A/HSPA9/PI3K-AKT regulatory axis?",{"text":121,"@type":113},"Mechanistic assays and rescue experiments show that HSPA9 overexpression restores PI3K/AKT activation and reverses the malignant suppression caused by TIMM8A knockdown; xenograft data further confirm reduced tumor growth with TIMM8A silencing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352118,1790193398,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nLoss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4  \nYi Wu 1,2,†, Rujiao Liu 2,3,†, Jian Zhang 2,3,* and Shuiping Gao 2,3, *  \nAcademic Editor: Kazuhiko Kuwahara  \nReceived: 14 July 2026  \nRevised: 13 August 2026  \nAccepted: 14 August 2026  \nPublished: 18 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China; [wuyi_smile@163.com](wuyi_smile@163.com)  \n2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; [06301010252@fudan.edu.cn](06301010252@fudan.edu.cn)  \n3 Phase I Unit, Fudan University Shanghai Cancer Center, Shanghai 200032, China  \n* [Correspondence: jianz@fudan.edu.cn](Correspondence: jianz@fudan.edu.cn) (J.Z.); [gsp7317@126.com](gsp7317@126.com) (S.G.)† These authors contributed equally to this work.  \nAbstract  \nTo investigate the role and underlying mechanisms of TIMM8A in breast cancer progression. The expression of TIMM8A in breast cancer tissues and cell lines was assessed. Functional assays were performed to evaluate the effects of TIMM8A knockdown on proliferation, metastasis, and apoptosis in BT549 and MCF-7 cells. Co-immunoprecipitation (Co-IP) and ubiquitination assays were used to examine the interaction between TIMM8A and HSPA9, as well as the involvement of the E3 ubiquitin ligase RNF4 . PI3K/AKT pathway activity was assessed by Western blotting. In vivo tumor growth was evaluated using a xenograft mouse model. TIMM8A was significantly upregulated in breast cancer tissues and cell lines, and high TIMM8A expression correlated with poor prognosis. TIMM8A knockdown suppressed proliferation and metastasis while inducing apoptosis in vitro. Mechanistically, TIMM8A interacted with HSPA9 and maintained its protein stability by inhibiting RNF4-mediated ubiquitination and degradation, thereby sustaining PI3K/AKT signaling activation. Conversely, TIMM8A depletion reduced HSPA9 stability and attenuated the pathway. Rescue experiments confirmed that HSPA9 overexpression restored PI3K/AKT activation and reversed TIMM8A-knockdown-induced malignant suppression. In vivo, TIMM8A silencing efficiently inhibited tumor growth, accompanied by reduced HSPA9 and Ki-67 expression and decreased PI3K/AKT phosphorylation. TIMM8A promotes breast cancer progression through the TIMM8A/HSPA9/PI3K/AKT regulatory axis, highlighting TIMM8A as a promising prognostic biomarker and potential therapeutic target for breast cancer.  \nKeywords: TIMM8A; HSPA9; RNF4; ubiquitination; breast cancer  \n1. Introduction  \nBreast cancer ranks first in both incidence and mortality among women worldwide. According to 2022 global statistics, breast cancer accounts for 23.8% of all female cancers and 15.4% of cancer-related deaths, posing a serious threat to women’s health worldwide [1] . Compared with other tumor types, the diagnosis and treatment of breast cancer have always been at the forefront of precision medicine. Clinically, based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth  \nfactor receptor 2 (HER2), and the proliferation marker Ki-67, breast cancer is classified into four major subtypes: Triple-negative breast cancer (TNBC), HER2-positive, Luminal A and Luminal B [2] . Although a great achievement has been made in breast cancer therapy, such as DS-8201 [3–6] and Dato-ADC [7], which have significantly improved the survival of patients with HER2-positive or TNBC, patients with advanced or distant metastatic disease still face formidable challenges [8] . Therefore, continuous exploration of novel therapeutic targets remains an indispensable part of breast cancer management. Given th","cbCailBLxR16kF7S","https://ap.wps.com/l/cbCailBLxR16kF7S","pdf",5665195,17,"English","# Introduction","[{\"question\":\"What is the primary purpose of this study on TIMM8A in breast cancer?\",\"answer\":\"The study investigates TIMM8A’s role and underlying mechanisms in breast cancer progression, focusing on how it affects key signaling and protein stability.\"},{\"question\":\"How does TIMM8A influence HSPA9 and its degradation?\",\"answer\":\"TIMM8A interacts with HSPA9 and maintains HSPA9 protein stability by inhibiting RNF4-mediated ubiquitination and degradation.\"},{\"question\":\"What evidence supports the proposed TIMM8A/HSPA9/PI3K-AKT regulatory axis?\",\"answer\":\"Mechanistic assays and rescue experiments show that HSPA9 overexpression restores PI3K/AKT activation and reverses the malignant suppression caused by TIMM8A knockdown; xenograft data further confirm reduced tumor growth with TIMM8A silencing.\"}]","Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4 | PDF",1790097777,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fea04143773fe250ca55cbb7ac213dd.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7c9fab7cd5f41f806ecd3dd31d9e5aa.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77d55a98380d3633814d660ad6d7ca9c.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25f50949dd2bcdb8d4fcf70b66cdaf47.webp",980,1385]